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ThioreductionThe reconstitution of biosynthetic pathways from heterologous hosts can help deﬁne the minimal genetic re-
quirements for pathway function and facilitate detailed mechanistic studies. Each of the three pathways for
the assembly of cytochrome c in nature (called systems I, II, and III) has been shown to function recombi-
nantly in Escherichia coli, covalently attaching heme to the cysteine residues of a CXXCH motif of a c-type cy-
tochrome. However, recombinant systems I (CcmABCDEFGH) and II (CcsBA) function in the E. coli periplasm,
while recombinant system III (CCHL) attaches heme to its cognate receptor in the cytoplasm of E. coli, which
makes direct comparisons between the three systems difﬁcult. Here we show that the human CCHL (with a
secretion signal) attaches heme to the human cytochrome c (with a signal sequence) in the E. coli periplasm,
which is bioenergetically (p-side) analogous to the mitochondrial intermembrane space. The human CCHL is
speciﬁc for the human cytochrome c, whereas recombinant system II can attach heme tomultiple non-cognate
c-type cytochromes (possessing the CXXCHmotif.) We also show that the recombinant periplasmic systems II
and III use components of the natural E. coli periplasmic DsbC/DsbD thiol-reduction pathway. This article is
part of a Special Issue entitled: Biogenesis/Assembly of Respiratory Enzyme Complexes.is, hexahistidine; B-PER, bacte-
l; cyt, cytochrome; MBP, malt-
e transferase.
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All c-type cytochromes function in the prokaryotic periplasm,
the thylakoid lumen, or the mitochondrial intermembrane space.
(See [1–4] for recent reviews on functions and assembly of c-type
cytochromes). Typical c-type cytochromes have two thioether
bonds that are formed between two cysteines and the two vinyl
groups of heme (at a CXXCH motif, where the histidine acts as an
axial ligand to the iron). This covalent linkage prevents heme loss
and indirect evidence shows that most c-type cytochromes are de-
graded without heme attachment [5, 6]. The assembly of a c-type
cytochrome requires that the heme and the apocytochrome are al-
ready transported to the periplasm or mitochondrial intermem-
brane space prior to attachment. Additionally, in vitro the heme
iron and the two cysteines must be reduced for attachment, this at-
tachment occurring spontaneously at the alpha carbons of the vinyl
groups [7, 8].Three systems have been described for cytochrome c assembly
(Fig. 1). Many Gram negative bacteria (including Escherichia coli),
archaea, and plant mitochondria use the system I pathway encoded
by ccm (cytochrome c maturation) genes (Fig. 1A). System I is the
most studied pathway and it involves apocytochrome c thiol-reduction
by a speciﬁc periplasmic thioredoxin protein called CcmG (HelX)
[9–11], which is itself reduced by the transmembrane DsbD (or
the related CcdA) [12–14]. Other proteins are involved in heme
export (CcmABCD), heme chaperoning (CcmE), apocytochrome
trafﬁcking and thiol redox (CcmH), and heme reduction (CcmF)
prior to heme attachment to apocytochrome c by CcmF/H complex
(recently reviewed in [1, 2]). Although the molecular mechanisms
underlying apocytochrome c recognition and heme attachment by
CcmF/H are poorly understood, many studies are in agreement
that system I can assemble a wide variety of c-type cytochromes,
with only the CXXCH as the recognition determinant for attachment
(e.g.[15–21]).
System II is present in some Gram negative bacteria (e.g. Helico-
bacter, Wolinella), Gram positives (e.g.Mycobacterium, Bacillus), cya-
nobacteria, and the chloroplast (Fig. 1B). Genetic analyses of bacteria
with system II have shown that a speciﬁc periplasmic thioredoxin
(CcsX) [22], and again the generic DsbD (or CcdA) protein [22–26]
are required. System II also involves export of heme, recognition of
the apocytochrome c, and heme attachment, but these functions are
carried out by the CcsBA integral membrane protein [27]. This was
established by using a recombinant E. coli deleted for all its ccm
genes, which was able to synthesize periplasmic cytochrome c4
Fig. 1. Schematic models of the three c-type cytochrome assembly pathways (Systems I, II, and III). The cartoons are reproduced in modiﬁed form from Kranz et al. [1].
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Although most organisms with system II have separate ccsB and ccsA
genes, a few organisms have naturally fused ccsBA genes. Further
studies on this recombinant CcsBA have indeed shown that the pro-
tein acts as a heme exporter and cytochrome c synthetase [27]. How-
ever, questions remain for the recombinant CcsBA as to what
comprises the substrate recognition determinants and how the apoc-
ytochrome c is reduced (e.g. whether Dsb proteins are involved) [28,
30]. Here we address these questions.
System III appears to be the simplest, comprised of an enzyme
ﬁrst discovered by yeast genetic analyses [31–33], referred to as cy-
tochrome c heme lyase (CCHL) (Fig. 1C). This enzyme has also been
referred to as holocytochrome c synthase (HCCS), cytochrome c
synthase, or cytochrome c synthetase e.g.[34–36]. Here we use
CCHL to refer to the system III enzyme. Despite evidence that it is a
soluble protein in the mitochondrial intermembrane space, and its
involvement in some rare human genetic defects [34–36], it is a
poorly understood enzyme [37]. The evidence that it represents the
sole cytochrome c synthetase comes in part from reconstitution of
its activity in the E. coli cytoplasm, using its cognate cytochrome c
(e.g. [15, 38–40]). Interestingly, although yeast has two separate
CCHLs, one for cytochrome c[31] and a second related enzyme for cy-
tochrome c1 (CC1HL) [33], humans have a single CCHL [3, 34]. The
human CCHL appears to recognize both cytochromes c and c1. More-
over, the yeast CCHL can be over-expressed or easily selected to rec-
ognize both cytochromes [3, 41]. Recently, the recombinant
cytoplasmic CCHL from yeast was used to begin to investigate apoc-
ytochrome c recognition determinants (i.e. residues or regions in cy-
tochrome c required for heme attachment by CCHL) [39, 40, 42]. One
of the caveats to studying cytoplasmic synthesis of c-type cyto-
chromes is that no direct comparison to the periplasmicrecombinants (systems I or II) can be made with respect to apocyto-
chrome c folding and/or suitability for heme attachment. Here, we
test whether a periplasmic recombinant human CCHL with a peri-
plasmic human cytochrome c is functional (to allow such compari-
sons). We also address what endogenous periplasmic thiol
reduction proteins are necessary.
2. Materials and methods
2.1. Bacterial growth conditions
E. coliwere grown aerobically in Luria–Bertani (LB)media (Difco) at
37 °Cwith shaking at 300 rpm. Antibiotic concentrations are as follows:
50 μg mL−1 carbenicillin (carb), 20 μg mL−1 chloramphenicol (cm)
and 100 μg mL−1 kanamycin (km). Expression of pRGK333 (CcmABC-
DEFGH; system I) [28], pRGK368 (CcsBA; system II) [29], pRGK399
(pMALp2x:CCHL; system III), and pRGK400 (pET226xHis:CCHL; sys-
tem III) was induced by 1 mM isopropyl-β-D-thiogalactopyranoside
(IPTG) and expression of pRGK332 (Cyt c4) [28], pRGK389 (Cyt c2;
pBADc2:6xHis), pRGK390 (human CycS; pBADCycS:6xHis), and
pRGK401 (human CycS:R. capsulatus Cyt c2 chimera; pBADCycS-c2:
6xHis) was induced by 0.2% arabinose.
2.2. Plasmid construction
The human CCHL was ampliﬁed from a cDNA clone (Origene) and
cloned in frame into the EcoRI and HindIII sites of pMalp2x (New En-
gland Biolabs) to create pRGK399, a periplasmically targeted maltose
binding protein (MBP) fusion (see Table 1 for strains and plasmids,
Table S1 for oligonucleotide sequences). An N-terminal hexahisti-
dine-tagged periplasmically targeted (pelB signal) version of the
Table 1
Description of strains and plasmids used in this study.
Strain or plasmid Description and purpose Reference
RK103 Δccm E. coli strain deleted for all ccm genes [28]
RK106 ΔccmΔdsbA E. coli strain This study
Generated by P1 phage transduction
using strains JW3832 and RK103
RK107 ΔccmΔdsbB E. coli strain This study
Generated by P1 phage transduction
using strains JW5182 and RK103
RK108 ΔccmΔdsbC E. coli strain This study
Generated by P1 phage transduction
using strains JW2861 and RK103
RK109 ΔccmΔdsbD E. coli strain This study
Generated by P1 phage transduction
using strains JW5734 and RK103
RK110 ΔccmΔdsbG E. coli strain This study
Generated by P1 phage transduction
using strains JW0597 and RK103
RK112 Δccm BL21(DE3) E. coli stain This study
Generated by P1 transduction with RK103
TC127034 cDNA clone from Origene-plasmid template Origene
for construction of pRGK390 and pRGK391
MGC12367 E. coli strain from ATCC with plasmid ATCC
PCR template for construction of pRGK392
pRGK333 Expression of GST-tagged CcmABCDEFGH [28]
(system I) from E. coli
pRGK368 Expression of GST-tagged CcsBA [29]
(fused system II) from H. hepaticus
pRGK330 pBAD24 based, chloramphenicol resistant [28]
plasmid for arabinose inducible expression
pRGK399 Periplasmic expression MBP-tagged human This study
cytochrome c heme lyase (CCHL; system III)
pRGK400 Periplasmic (pelB signal) of N-terminal 6x: This study
His-tagged human CCHL
pRGK331 Expression of cytochrome c4 from B. [28]
pertussis fused to alkaline phosphatase.
PCR template for construction of pRGK392
pRGK332 Expression of cytochrome c4 reporter [28]
from B. pertussis
pRGK389 Expression of cytochrome c2 reporter This study
from R. capsulatus
pRGK390 Periplasmic (cyt c4 signal) expression of This study
human cytochrome c CycS reporter
pRGK401 Periplasmic (cyt c4 signal) expression of This study
chimeric human CycS and R. capsulatus
cytochrome c2 reporter
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above cDNA clone and in-frame insertion into the NcoI and HindIII
sites of pET22b (EMD Biosciences). The cytochrome c2 gene cycA,
with its natural signal sequence, was ampliﬁed from R. capsulatus
DNA and cloned into the KpnI and PstI sites of pRGK330 [28] to cre-
ate pRGK389. The human cytochrome c gene cycS was ampliﬁed
from cDNA clone MGC12367 (ATCC) and cloned into NotI and KpnI
sites of pRGK331 [28] that was ampliﬁed to use the cytochrome c4
signal sequence to create pRGK390. The human cytochrome c gene,
containing a deletion of the DNA corresponding to amino acids 4–
22, along with the surrounding plasmid was ampliﬁed from
pRGK390 with phosphorylated oligonucleotides, containing the R.
capsulatus Cyt c2 DNA corresponding to amino acids 2–20, and
blunt end ligated to create pRGK401.
2.3. Knockout strain construction
E. coli strains with knockout mutations in dsb genes were
obtained from the Keio strain collection [43, 44]. The knockout mu-
tations were transduced into RK103 (Δccm) [28] by P1 phage trans-
duction [45]. Brieﬂy, P1 phage were grown ﬁrst in LB media, 5 mM
CaCl2, 0.2% glucose, with a dsb mutant strain as the donor strain.
Cells were killed by addition of chloroform to the growth media
and the phage were isolated. Dilutions of isolated phage (100 μL)
were then incubated with 100 μL RK103 cell culture (O.D.600=0.8–
1.0) in 5 mM CaCl2 and 100 mM MgSO4 for 30 minutes at 37 °C.
Physical interaction between the phage and cells was disrupted by
addition of 66.7 mM sodium citrate pH 5.5 then the culture was
added to 1 mL LB broth and incubated for 1 hour at 37 °C with shak-
ing at 300 rpm. Transductants were selected by growth on LB-Kan
plates and veriﬁed by PCR.
2.4. Protein puriﬁcation
Hexahistidine-tagged proteins were puriﬁed with Talon afﬁnity
resin (Clonetech) from whole cell lysates. E. coli cultures of RK103
(Δccm) containing pRGK399 (pMalp2x:CCHL) or pRGK333 (system
I) and pRGK390 (pBADCycS:6xHis) or RK112 (BL21(DE3) Δccm)
containing pRGK400 (pET226xHis:CCHL) were inoculated (to 1%)
with fresh overnight culture in LB medium supplemented with the
appropriate antibiotics. One liter cultures were grown to an OD600
of 0.8–1.0 and protein over-expression was induced with IPTG and
arabinose or IPTG alone for 4 hours (system I matured) or 12–
14 hours (system III matured). Following induction the cells were
harvested at 6000g for 10 min and the cell pellet was resuspended
in 3.5 mL, per gram of cell pellet, of 1×Talon buffer (50 mM sodium
phosphate buffer, 300 mM NaCl, pH 7.0) that was supplemented
with 0.1 mg mL−1 egg white lysozyme (Sigma-Aldrich) and 1 mM
phenylmethanesulfonyl ﬂuoride (PMSF; Sigma-Aldrich). Following
gentle agitation on ice (20 min), the cell suspensions were sonicated
(on ice) for 2×3 min using a Branson 250 sonicator (50% duty, 70%
output), and cellular debris was removed by centrifugation
(10,000g, 15 min, 4 °C). The clariﬁed lysate (Load) was passed by
gravity ﬂow over Talon resin, washed with 10 column volumes of
1× Talon buffer (Wash 1), ﬁve column volumes of 1× Talon buffer
containing 5 mM imidazole (Wash 2), and eluted with ﬁve column
volumes of 1× Talon buffer containing 150 mM imidazole (Elution).
To ensure that all hexahistidine-tagged protein was eluted from
the resin, the cobalt ions were stripped with ﬁve column volumes
of 1× Talon buffer containing 0.2 M EDTA (Strip). The elution frac-
tion was concentrated approximately 10-fold with an Amicon 10 K
spin ﬁlter (ThermoFisher Scientiﬁc). The human CycS:6xHis was fur-
ther puriﬁed (N95%) by passage over DEAE Sepharose Fast Flow (GE
Healthcare). The 1× Talon buffer (containing 150 mM imidazole)
was exchanged for a Tris based buffer (20 mM Tris, 25 mM NaCl,
pH 8.0; loading buffer) and the ﬁnal volume was brought to 4 mL.The buffer-exchanged Talon puriﬁed CycS:6xHis was loaded onto a
2.5 mL packed bed volume DEAE column, the ﬂow through was col-
lected along with another 2×column volumes of loading buffer
(total 9 mL), and the column was washed with successive 2×column
volumes of loading buffer containing 0.1 M, 0.3 M, 0.5 M, and 1 M
NaCl, respectively. Using these conditions (i.e. loading buffer at pH
8.0) the human CycS:6xHis did not bind with the DEAE resin and
thus, was present in the ﬂow through. For mass spectrometry analy-
sis the DEAE puriﬁed CycS:6xHis (matured by both system III and
system I) was dialyzed against sterile distilled de-ionized H20 and
concentrated as above.
2.5. E. coli cellular protein fractionation
Isolation of periplasmic proteins was by a modiﬁcation of the
method of Feissner et al. [28]. E. coli cultures (100 mL) of RK103
(Δccm) or RK112 (BL21(DE3) Δccm) containing a system plasmid,
pRGK333 (pGEXCcmABCDEFGH), pRGK399 (pMALp2x:CCHL) and a
reporter plasmid, pRGK400 (pET226xHis:CCHL) and pRGK390
(pBADCycS:6xHis), pRGK389 (pBADc2:6xHis) or pRGK401 (pBAD-
CycS-c2:6xHis chimera) were grown to an OD600 of 0.6 to 0.8, IPTG
(1 mM) and arabinose (0.2%, when required) were added for protein
over-expression, and induction proceeded for 12–14 hours. Cells
were harvested at 6,000 g for 10 min at 4 °C and washed once at
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resuspended in 10 mL of 100 mM Tris containing 20% (w/v) sucrose,
warmed to 37 °C, 0.1 mg mL−1 lysozyme was added, and the suspen-
sion was gently rocked at 37 °C for 15 min. Periplasmic proteins were
released from the spheroplasts by treatment with EDTA (10 mM ﬁnal
concentration) at 37 °C and separated by centrifugation at 12,000g for
10 min. The supernatant was saved as the periplasmic protein frac-
tion. The spheroplasted cell pellet was resuspended in phosphate
buffered saline (10 mM phosphate, 137 mM NaCl, 3 mM KCl,
pH7.4), sonicated on ice for 3×20 sec (50% duty, 15% output on a
Branson Model 250 sonicator), and the lysate was cleared via centri-
fugation at 12,000 g for 15 min. The membranes were separated from
the cytoplasm by ultracentrifugation at 100,000g for 1 hour and solu-
bilized in PBS containing 1% n-Dodecyl-β-D-maltoside. Crude protein
extraction for cytochrome c assembly activity assays was accom-
plished with B-PER (Bacterial Protein Extraction Reagent; Pierce-
Thermo Scientiﬁc). Brieﬂy, 5-mL LB cultures, supplemented with the
appropriate antibiotics, of a given strain of E. coli Δccm (or Δccm
with single dsbA, dsbB, dsbC, dsbD, or dsbG deletions) containing the
indicated system plasmid (pRGK333, pRGK368, pRGK399, or
pRGK400) and/or the indicated cytochrome c over-expression plas-
mid (pRGK332, pRGK389, pRGK390, or pRGK401) were inoculated
with 200 μl of fresh overnight culture and grown for 2.5 hours shak-
ing at 37 °C. Protein over-expression was induced with IPTG and
arabinose for 4 hours (system I matured cytochrome c) or 12–
14 hours (system II and III matured cytochrome c). For experiments
containing DTT, a ﬁnal concentration of 3 mM DTT was added to the
5-mL cultures at the time of IPTG induction, incubation proceeded
for 30 min, and then the cytochrome c reporters were induced with
arabinose for the times given above. The cells were pelleted at
4,000 g for 10 min and resuspended in 200 μl B-PER.
2.6. Heme stains and Western blots
Total protein concentration was determined by BCA assay (Pierce
Thermo Scientiﬁc) or A280 with a Nanodrop Spectrophotomer (Ther-
mo Scientiﬁc). Protein fractions were subjected to SDS-PAGE, trans-
ferred to a Hybond C nitrocellulose membrane (GE Healthcare) and
heme stains were conducted as described [46] using SuperSignal
West Femto Maximum Sensitivity Substrate (Pierce-Thermo Scientif-
ic). Western blots were performed with anti-His antibody (1:5000;
Santa Cruz Biotechnology) with protein A peroxidase as the second-
ary label and chemiluminescent signal was developed with Super-
Signal West Femto. Both heme stains and Western blots were
visualized with an LAS-1000plus Luminescent Image Analyzer CCD
camera system (Fujiﬁlm/GE Healthcare).
2.7. Other methods
Reduced (sodium dithionite; Sigma-Aldrich) and as puriﬁed (air
oxidized) cytochrome c UV–vis absorption spectra were recorded
on a UV2101PC scanning spectrophotometer (Shimadzu). ESI-MS
was performed by the Proteomics and Mass Spectrometry Facility
at the Donald Danforth Plant Science Center on DEAE puriﬁed
human CycS:6xHis.
3. Results and discussion
3.1. Expression of a functional CCHL (i.e. cytochrome c synthase) in E. coli
The human gene encoding CCHL was cloned in-frame to the E.
coli gene (malE) encoding the periplasmic maltose binding protein
(MBP) (Fig. 2A). Note that MBP contains its natural signal sequence
for export to the periplasm, and such fusion proteins can be puriﬁed
in one step on amylose-agarose columns. E. coli RK103 (Δccm) with
this plasmid as well as RK103 with pMal-p2x (malE-only plasmidwithout CCHL) were induced with IPTG, periplasmic fractions were
separated by SDS-PAGE, and stained with Coomassie Blue (Fig. 3).
Both preparations show a major polypeptide the size of MBP
(42KD). It is often the case that fusion proteins are proteolysed at the
fusion junction resulting in MBP. With pMalp2X, a larger polypeptide
(~53 kDa) that represents the fusion of lacZ' from the blue/white
screening vector is also present (labeled as MBP:lacZ' in Fig. 3). This
polypeptide is absent from preparations of the MBP:CCHL, as expected,
and two new polypeptides are observed. One of these is likely the full
length MBP:CCHL, migrating at approximately 83 kDa, the other is a
truncated product of 59 kDa (labeled MBP:CCHL*).
To determine if the human CCHL that contains the MalE periplas-
mic signal sequence is functional in E. coli, the human cytochrome c
gene (cycS) was engineered into an arabinose-inducible pBAD plas-
mid (Fig. 2C) which is compatible with pMalp2x. A periplasmic signal
sequence from Bordetella pertussis cytochrome c4 was engineered in
frame to the N-terminus of CycS, and cloned downstream of the
arabinose-inducible promoter. We have previously shown that the
cytochrome c4 signal is efﬁciently processed in the periplasm of E.
coli Δccm expressing recombinant system I and II [28]. For afﬁnity pu-
riﬁcation a hexahistidine tag was engineered onto the C-terminus of
CycS. Expression and heme attachment to this periplasmically tar-
geted CycS was initially tested using the E. coli system I pathway, all
eight ccm genes expressed from pRGK333 in E. coli RK103 (Δccm).
The human cytochrome c was expressed and assembled in the peri-
plasm, as is evidenced by the heme stain of polypeptides separated
by SDS PAGE (Supp Fig. 1), which suggests that CycS:6xHis with the
c4 signal is properly transported and folded in the periplasm. These
results are in agreement with system I cytochrome c maturation re-
quiring apocytochrome export to the periplasm for heme insertion
and folding [47]. [Note that because the heme is covalently attached,
even upon SDS PAGE the heme remains with the denatured polypep-
tide and is detected by staining for heme.] We next tested strain
RK103 (E. coli Δccm) containing pRGK399 (pMalp2x:CCHL) and
pRGK390 (pBADCycS:6xHis) for holoCycS:6xHis maturation. A cul-
ture containing the periplasmically targeted MBP:CCHL and
CycS:6xHis was induced and the hexahistidine tagged CycS was puri-
ﬁed over a cobalt column (Fig. 4A). Although the imidazole-eluted
fraction showed multiple polypeptides (Fig. 4A, lane 7), one major
polypeptide at 13 kDa stained intensely for heme (Fig. 4B, lane 7).
Subsequent puriﬁcation of the imidazole-eluted fraction over a
DEAE column yielded (N95%) pure CycS (Fig. 4C, lane 3). This poly-
peptide (13 kDa) stained for heme (Fig. 4D), and, upon UV–vis spec-
troscopy, the pure protein showed the characteristic alpha absorption
peak at 550 nm (Fig. 5A). The puriﬁed preparation was analyzed by
ESI-MS to establish whether the signal sequence was cleaved and to
conﬁrm covalent heme attachment (Fig. 5B). All masses are given
as ± 1 Dalton. Three cleavage products were detected of the masses
indicated in Fig. 5B (see "1, 2, 3") and are predicted with an attached
heme of 616 Daltons. (Note that the relative percentage of each holo-
CycS, as determined from mass spectrometry peak proﬁles, are given
to the right of the mass.) Even though each of the three predicted
polypeptides (Fig. 5B, see "1, 2, 3") was found to be cleaved at a po-
tential E. coli signal peptidase recognition site [48–50] we cannot
rule out some nonspeciﬁc proteases are also responsible for this
cleavage (in periplasm or cytoplasm). No polypeptides without
heme were detected, which is consistent with the premise that the
apocytochrome polypeptide is often degraded if heme is not attached
(e.g. see [1, 4]). CycS matured by system I was also puriﬁed, as given
above, and showed identical absorption maxima as system III ma-
tured CycS and a single polypeptide at 13329 Da was detected via
ESI-MS (data not shown). These results, e.g. the presence of full-
length MBP:CCHL in unpuriﬁed periplasmic shock fractions (Fig. 3
lane 3) and holoCycS that has the same mass and spectral character-
istics as system I matured, suggest that at least some of the holoCycS
is matured in the E. coli periplasm.
Fig. 2. Recombinant plasmids with the human system III (A and B) and indicated c-type cytochromes (C, D, and E).
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periplasm, thus we wanted to conﬁrm the potential periplasmic syn-
thesis using a different secretion signal for CCHL (from pelB), and aFig. 3. Human cytochrome c heme lyase expressed as a MBP:CCHL fusion protein in the
E. coli periplasm. Coomassie Blue stained SDS-PAGE proﬁle of periplasmic shock pro-
teins from IPTG-induced RK103 (Δccm) expressing pMalp2x (lane 2) and pMalp2X:
CCHL (lane 3). Protein molecular weight standards are shown (labeled M) in lane 1
with indicated molecular masses (left).different afﬁnity tag for puriﬁcation, an N-terminal hexahistidine tag
rather than a MBP fusion (see Fig. 2B). We chose the an N-terminal
hexahistidine tag because previous work with cytoplasmically
expressed yeast CCHL suggested the N-terminal 6xHis tag was more
soluble and was over-expressed to higher levels than the non-
hexahistidine tagged version [15, 38]. The 6x:His-tagged CCHL, over-
expressed from pRGK400 (pET226xHis:CCHL), could be partially puri-
ﬁed over a cobalt column (Fig. 6A), and various polypeptides reacted
with hexahistidine antisera upon Western blotting (Fig. 6B). From
the Western blot, full-length CCHL of approximately 30 kDa was pre-
sent in the load fraction (Fig. 6B, lane 2) and puriﬁed fraction (lane 6),
which suggests that at least some of the CCHL is properly folded and
stable. Two other immunoreactive polypeptides were observed in
the pure fraction (Fig. 6B, lane 6), yet it is clear that in the load (lane
2) full-length CCHL is the major polypeptide. Thus, some of the
CCHL is proteolysed during puriﬁcation. When this plasmid construct
is transformed into E. coli BL21(DE3) Δccm (RK112) that also pos-
sesses the cycS gene (with signal; pBADCycS:6xHis), human cyto-
chrome c is synthesized, as detected by heme staining of periplasmic
shock proteins (Fig. 6C, lane 1) and no holocytochrome is detected
(lane 2) in the absence of CCHL (pET226xHis:CCHL). We conclude
that CCHL can fold and properly function with its cognate cytochrome
c in the bacterial periplasm. An important implication of these results
916 C.L. Richard-Fogal et al. / Biochimica et Biophysica Acta 1817 (2012) 911–919is that some reduced heme is available in the periplasm for cyto-
chrome c assembly by CCHL. Possibly this is a ramiﬁcation of the pe-
ripheral association of CCHL [51] with the outer leaﬂet of the
cytoplasmic membrane, where the amphipathic and still reduced
heme may bind directly to CCHL for subsequent attachment. We
have previously speculated that non-speciﬁc “ﬂippases” may ﬂip
heme from inner leaﬂet to outer leaﬂet in a manner similar to phos-
pholipid “ﬂipping”, as a mechanism to “export” heme for CCHL [1]
(see Fig. 1C). Nevertheless, the levels of human cytochrome cmatured
by periplasmic CCHL are very low when compared to system I (see
below). Since a previous study indicated that cytoplasmically matured
yeast cytochrome c (by cytoplasmic CCHL) was up to two-fold more
than a recombinant system I [15], we estimate that in our study at
least ten- to one hundred- fold lower levels are periplasmically at-
tached (compared to system I, thus to cytoplasmic CCHL). This may
be a ramiﬁcation of lower levels of available reduced heme, or to the
secretory or folding requirements in the periplasm.Fig. 5. Reduced minus oxidized UV-vis absorption spectra and ESI mass spectrometry
analysis of puriﬁed human cytochrome cmatured by MBP:CCHL. (A) UV-vis absorption
spectra of human CycS expressed from RK103 (Δccm) containing pRGK399 (pMalp2x:
CCHL) and pRGK390 (pBADCycS:6xHis). The absorption maxima are denoted with ar-
rows. (B) Amino acid sequence of the cytochrome c4 signal:CycS. The signal sequence is
underlined, the CXXCH heme binding motif is bolded and the cleavage sites, as deter-
mined by ESI-MS, are denoted with arrows. The molecular masses (Da) and relative
percentages of each cleaved product, as deduced from the mass spectrometry peak
proﬁle, are shown below the amino acid sequence.3.2. Apocytochrome c recognition requirements of systems II and III
Many studies have been carried out on the substrate recognition
of system I, with the conclusion that naturally only the CXXCH ap-
pears to be necessary [16–20, 52]. However the substrate recogni-
tion requirements for system II are not as well studied. A recent
report using our Helicobacter pylori ccsBA recombinant approach
indicated that multiple c-type cytochromes were matured [21], sug-
gesting that system II requires only the CXXCH motif for recogni-
tion. To further examine recognition determinants of system II,
three heterologous cytochromes c were expressed (Fig. 2C, D, and
pBADCytc4:6xHis [28]) in E. coli strain RK103 (Δccm) in the pres-
ence or absence of the H. hepaticus CcsBA system II fusion protein.
Heme stains of B-PER-isolated fractions were conducted to detect
assembled cytochromes c. In the absence of CcsBA, no cytochrome
c is assembled (Fig. 7A, lanes 1, 3 and 5). However, when CcsBA is
present, all three periplasmic cytochromes c contain covalently at-
tached heme (Fig. 7A, lanes 2, 4 and 6), demonstrating that system
II is capable of maturing diverse cytochromes c. These include theFig. 4. Puriﬁcation of hexahistidine tagged human cytochrome c (CycS) produced in
IPTG- and arabinose-induced RK103 (Δccm) by pMALp2X:CCHL (MBP:CCHL; pRGK
399). SDS-PAGE of protein puriﬁcation fractions stained with (A and C) Coomassie
Blue and (B and D) heme stain. Hexahistidine-tagged Talon puriﬁcation fractions
(panel A) are indicated above each lane, where lane 1 (L; crude extract load), lane 2
(FT; Flow Through), lane 3 (Wash 1), lane 4 (Wash 2), lane 5 (EDTA strip), and lane
7 (imidazole elution). Note: The imidazole elution was performed before the EDTA
strip. DEAE puriﬁcation fractions are indicated above panel C where lane 2 (Talon elu-
tion as load), lane 3 (ﬂow through), and lane 4 (0.3 M NaCl wash). Protein molecular
weight standards are shown (labeled M) in lane 6 (A and B) and lane 1 (C and D)
with the masses (kDa) shown on the left of A and C. The position of CycS is shown in
the ﬂow through with an arrow on the right.diheme cytochrome c4 from B. pertussis (system II), cytochrome c2
from R. capsulatus (system I), and the human (system III) cyto-
chrome c. Our results are in agreement with the study by Goddard
et al. who showed that CcsBA from H. pylori matures monoheme cy-
tochromes from the system I organisms Paracoccus denitriﬁcans and
Hydrogenobacter thermophilus[21]. We concur that the feature of
apocytochromes c recognized by CcsBA is the CXXCH motif. Note
that rare “alternative” CcsBA synthetases have been shown to recog-
nize motifs other than CXXCH, such as CXXCK and CX15CH [53, 54],
but that here we have studied the more common system II CcsBA.
It has been largely accepted that the mitochondrial CCHLs may
have more stringent recognition requirements than the bacterial sys-
tems (e.g. more than CXXCH) [31, 33]. Recombinant studies of CCHLs
in the E. coli cytoplasm [15, 38–40] and in yeast mitochondria [3, 41,
42] point to expanded recognition requirements (i.e. more than sim-
ply CXXCH or XXCH) [55]. Recently, studies using the cytoplasmic
recombinant CCHL have started to deﬁne exact residues in apocyto-
chrome c that are important for the cognate CCHL recognition [39,
40]. To address possible folding defects (rather than recognition de-
fects), the same recombinant c-type cytochromes were assembled by
system I in E. coli[39]. However these controls (system I) require the
engineering of a signal sequence, thus not allowing exact compari-
son of substrates (or folding environments, periplasm versus cyto-
plasm). One of the uses of the recombinant system III (CCHL)
described here is to facilitate direct comparisons of identical sub-
strates in the same cellular compartment (periplasm). We test this
approach by focusing on the human cytochrome c and the structur-
ally related soluble monoheme cytochrome c2[56–58] from R.
Fig. 6. Hexahistidine-tagged human CCHL (with a periplasmic signal) attaches heme to
human cytochrome c. Cobalt (Talon) resin puriﬁcation of IPTG-induced 6xHis:CCHL
(pET226xHis:CCHL; pRGK400) expressed in RK112 (BL21(DE3) Δccm). Puriﬁcation
fractions run on SDS-PAGE and detected with (A) Coomassie Blue stain and (B) 6xHis
antisera by Western blot. Protein fractions are given above each lane, where lane 2
(L; crude extract load), lane 3 (ﬂow through), lane 4 (wash 1), lane 5 (wash 2), lane
6 (imidazole elution). (C) Heme stain of periplasmic shock proteins from IPTG- and
arabinose-induced RK112 containing pRGK400 and pRGK390 (lane 1; labeled SysIII
Δccm) or pRGK390 only (lane 2; labeled Δccm). Protein molecular weight standards
are shown (labeled M) in lane 1 (A and B; masses on left) and lane 3 (C; masses on
right). The position of 6xHis:CCHL and its proteolytic products (A and B) and of holo-
CycS:6xHis (C) are denoted with arrows.
Fig. 7.Maturation of various c-type cytochromes by recombinant CcsBA (system II) and
CCHL (system III). (A) Representative heme stains (three trials) of arabinose-induced,
soluble B-PER extracts (40 μg) from RK103 (Δccm; lanes 1, 3, and 5) or RK103 contain-
ing pRGK368 (Sys II; CcsBA) and pRGK332 (lane 2; pBADCytc4:6xHis), pRGK389 (lane
4; pBADCytc2:6xHis), or pRGK390 (lane 6; pBADCycS:6xHis). (B) Amino acid sequence
alignment of the N-termini of R. capsulatus cytochrome c2, the human Cyc S, and the
chimeric human CycS:c2. The vertical lines denote the 19 amino acid region that was
“swapped” in the chimera. (C) Heme stain of IPTG- and arabinose-induced periplasmic
shock proteins (approx. 100 μg) from RK103 containing pRGK333 (SysI; system I) and
pRGK390 (lane 1; pBADCycS:6xHis), pRGK389 (lane 2; pBADCytc2:6xHis), pRGK401
(lane 3; CycS-c2; pBADCycS-c2:6xHis chimera) or pRGK399 (SysI; pMALp2xCCHL) con-
taining pRGK390 (lane 4), pRGK389 (lane 5), pRGK401 (lane 6). The sizes of the re-
spective holocytochromes c are denoted with arrows.
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c, the R. capsulatus cytochrome c2, and a chimeric molecule in which
the human cytochrome c had a 19 residue region (encompassing the
CXXCH) substituted with the analogous region of the R. capsulatus
cytochrome c2 (Fig. 7B). System I recognized and assembled all
three substrates (Fig. 7C, lanes 1–3), which further conﬁrms that sys-
tem I can mature a wide variety of c-type cytochromes. However, the
human CCHL recognized only its cognate human cytochrome c
(Fig. 7C, lane 4) and not the cytochrome c2 (lane 5) or chimera
(lane 6). Because the expression level of system III was lower than
that of system I, as noted previously with recombinant system II
[28, 29], we concentrated by six-fold the recombinant periplasmic
shock proteins and still no holocytochrome c2 or chimera are
detected (data not shown). We conclude that CXXCH is not sufﬁcient
for CCHL recognition, and that other residues within this region (i.e.of the 19 residues of the human cytochrome c deﬁned in Fig. 7B) are
important for recognition by human CCHL. This conclusion is consis-
tent with previous cytoplasmic studies in E. coli that suggested the
N-terminus (up to and including the CXXCH) of the apocytochrome
c are important and sufﬁcient for yeast CCHL activity (e.g. [40, 47]).
Further analysis will be necessary to elucidate the exact residues
necessary for recognition.
3.3. The periplasmic thiol redox requirements of recombinant system
II and III
When results on the ﬁrst functional recombinant system II were
published [28], a commentary on the achievement [30] suggested
that one signiﬁcant question was what periplasmic thiol oxidation
and reduction pathway(s) from E. coli were used. For secreted
(and membrane) proteins the E. coli Dsb system is one of the best
understood pathways for disulﬁde bond formation [59–61]. DsbA
and DsbB represent the major pathway for oxidation of disulﬁdes
in the periplasm. For thiol reduction, the integral membrane protein
DsbD transfers reducing equivalents from the cytoplasm to periplas-
mic thioredoxin-type proteins such as DsbC, or to CcmG (HelX) in
the case of the natural system I in E. coli (see Fig. 1A). (Note that de-
letion of the ccm operon, necessary for studies on the recombinant
system II and III, removes ccmG also). In order to determine which
Dsb proteins, if any, are required for recombinant systems, deletions
of selected dsb genes were constructed in a Δccm background. Using
the recombinant system plasmids and selected cytochrome c expres-
sion plasmids, the attachment of heme was investigated in each
Fig. 8. Assembly of c-type cytochromes by CcsBA and CCHL in E. coli strains deleted of
the indicated genes. Representative heme stains (based on three trials) of soluble B-
PER extracts (40 μg) of IPTG- and arabinose-induced ccm or ccm dsb knockout(s) (indi-
cated above each lane), expressing pRGK368 (CcsBA) and pRGK332 (pBADCytc4:6xHis;
A and B) or pRGK399 (pMalp2x:CCHL) and pRGK390 (pBADCycS:6xHis; C and D).
Panels C and D lane 7 (No Sys) represent IPTG- and arabinose-induced E. coli ccm con-
taining only pRGK390. B-PER extracts of induced E. coli strains where exogenous 3 mM
DTT was included during growth and induction are shown in B and D. The positions of
holoCytc4 and holoCycS are denoted with arrows.
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little to no cytochrome c4 (Fig. 8A), and these defects were largely
corrected by adding exogenous DTT (Fig. 8B). Neither the dsbA nor
dsbB mutant showed defects in assembly, suggesting that formation
of a disulﬁde is unnecessary under these growth conditions. Various
studies have suggested that sometimes DsbA and/or DsbB are neces-
sary for the natural system I-mediated synthesis, and sometimes
they are dispensable [13, 14, 62]. Such variation could be due to aer-
obic versus anaerobic growth conditions, but we have not studied
this further. The requirement for DsbC and DsbD suggests that
some of the apocytochrome c4 (CXXC) may undergo oxidation (e.g.
oxygen-mediated), and DsbD-/DsbC-mediated thiol reduction is nec-
essary. DsbC encodes a periplasmic thioredoxin-like protein, thus we
propose that it functions in the reduction of apocytochrome c direct-
ly, and is re-reduced by DsbD. In the case of recombinant system III
(CCHL) and its cognate human cytochrome c (Fig. 8C, D), DsbC is
partially required (holoCycS is reduced by 80%), while the dsbD mu-
tant showed only 30% reduction (when averaged over three trials)
in cytochrome c assembly. It is possible that as the human cyto-
chrome c is exported it is more rapidly used by CCHL, thus its two
cysteines are reduced and ready for heme attachment to CXXCH.
(Alternatively, some of the holoCycS may be matured by unsecreted,
cytoplasmically located CCHL.) In both systems II and III, DTT in-
hibits cytochrome c production in the absence of DsbA (and in
Δccm). This result could be due to the osmofragility of dsbA- strains,
thus a pleiotrophic effect [63]. We conclude that under the aerobicconditions used, both recombinant systems II and III require some
thiol reduction and this periplasmic reduction is mediated by the
natural E. coli DsbC and/or DsbD proteins. For system III, the lack
of a strong DsbD requirement suggests that DsbC may be acting in
a DsbD-independent manner, thus DsbC can obtain reductant from
other periplasmic proteins directly or from reduced DsbA, as
shown previously [63, 64]. In addition to the thiol reduction require-
ment, DsbC might protect the apocytochrome c cysteines from sulfe-
nylation, which was recently reported as a function of DsbC [65].
The need for DsbC in system III underscores the conclusion that
heme attachment can occur in the periplasm by this recombinant
CCHL system, albeit at much reduced levels when compared to sys-
tem I (or to cytoplasmic CCHL). The absolute dependence of recom-
binant system II on DsbC and DsbD (and correction by exogenous
DTT), addresses how recombinant, periplasmic c-type cytochromes
in E. coli can be reduced using various recombinant assembly
systems (e.g. see [28, 30, 64].Acknowledgments
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